BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 33485186)

  • 21. An integration-free iPSC line (SDQLCHi013-A) derived from a patient with maple syrup urine disease carrying compound heterozygote mutations in BCKDHA gene.
    Zhang H; Ma Y; Li X; Yang X; Li Y; Guan J; Dong R; Gai Z; Liu Y
    Stem Cell Res; 2019 Dec; 41():101585. PubMed ID: 31775088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of a human induced pluripotent stem cell line (CSC-40) from a Parkinson's disease patient with a PINK1 p.Q456X mutation.
    Russ K; Marote A; Savchenko E; Collin A; Goldwurm S; Pomeshchik Y; Roybon L
    Stem Cell Res; 2018 Mar; 27():61-64. PubMed ID: 29331938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of an induced pluripotent stem cell line (ZZUSAHi002-A) derived from peripheral blood mononuclear cells of a healthy individual.
    Liu S; Niu S; Li Y; Xiong H; Li Y; Jian L; Zhang L
    Stem Cell Res; 2020 Oct; 48():101966. PubMed ID: 32911326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An integration-free iPSC line SDQLCHi025-A from a girl with multiminicore disease carrying compound heterozygote mutations in RYR1 gene.
    Zhang H; Ma Y; Lv Y; Wan Y; Zhao Q; Gai Z; Liu Y
    Stem Cell Res; 2020 May; 45():101775. PubMed ID: 32272370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T.
    Ma D; Ng SH; Zeng L; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():54-56. PubMed ID: 28395805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of an induced pluripotent stem cell line (ZJUi007-A) from a 11-year-old patient of Fabry disease.
    Zhu Y; Zhang L; Wang G; Zhao J; Hou X; Wu H; Xu Y; Mao J; Liu Z; Zhang J
    Stem Cell Res; 2021 Aug; 55():102475. PubMed ID: 34365103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-integrating episomal vectors induced pluripotent stem cell line (SDPHi001-A) from a healthy female individual.
    Shao J; Shao C; Jin Y; Wang X; Fan H; Yang G
    Stem Cell Res; 2021 Oct; 56():102540. PubMed ID: 34547706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human induced pluripotent stem cells line (PNUSCRi002-A) from a patient with Parkinson's disease carrying a R159W mutation in the GBA gene.
    Moon HJ; Lee N; Moon JY; Park KK; Lee JH; Kim JH
    Stem Cell Res; 2022 Dec; 65():102948. PubMed ID: 36274270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of a transgene-free iPS cell line (SDCHi003-A) from a young patient bearing a NPRL2 mutation and suffering from Epilepsy.
    Su S; Zhao F; Zhang H; Liu Y; Li Z; Zhang H; Wang Y; Fang F; Liu Y
    Stem Cell Res; 2024 Apr; 76():103366. PubMed ID: 38430737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant.
    Cheng YC; Huang CY; Ho MC; Hsu YH; Syu SH; Lu HE; Lin HI; Lin CH; Hsieh PCH
    Stem Cell Res; 2018 Apr; 28():1-5. PubMed ID: 29414410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of an induced pluripotent stem cell line (ZZUi020-A) from a patient with Parkinson's disease harboring the intermediate-length GGC repeat expansions in the NOTCH2NLC gene.
    Fan Y; Liu F; Fan LY; Mao CY; Liu H; Zhang C; Yuan YP; Yang J; Wang YL; Liu YT; Shi CH; Xu YM
    Stem Cell Res; 2021 Apr; 52():102257. PubMed ID: 33626493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of induced pluripotent stem cell line (RCMGi001-A) from human skin fibroblasts of a cystic fibrosis patient with p.F508del mutation.
    Kondrateva E; Adilgereeva E; Amelina E; Tabakov V; Demchenko A; Ustinov K; Yasinovsky M; Voronina E; Lavrov A; Smirnikhina S
    Stem Cell Res; 2020 Oct; 48():101933. PubMed ID: 32777768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of Parkinson's disease patient-derived human induced pluripotent stem cells line (PNUSCRi001-A) carrying a N227S mutation in GBA gene.
    Lee N; Moon HJ; Park SH; Moon JY; Park KK; Kim JH; Lee JH
    Stem Cell Res; 2022 Dec; 65():102959. PubMed ID: 36332465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of an induced pluripotent stem cell line (SDASi001-A) from a Schimke immune-osseous dysplasia patient with SMARCAL1 mutations.
    Wang X; Zhang H; Wang X; Zhou W; Dong L; Li N; He Q
    Stem Cell Res; 2023 Oct; 72():103217. PubMed ID: 37788557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells.
    Gao Y; Cheng Y; Wen J; Xiao D; Xu J; Cai C; Hu J
    Stem Cell Res; 2023 Jun; 69():103088. PubMed ID: 37099933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of an integration-free induced pluripotent stem cell line, FJMUUHi002-A, from a Rett syndrome patient with a heterozygous mutation p. R133C in MeCP2.
    Guo Y; Li J; Xie W; Huang H; Li JJ; Lin W; Lu YQ
    Stem Cell Res; 2024 Feb; 74():103268. PubMed ID: 38100910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene.
    Ma D; Zhou W; Ng EY; Zeng L; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():45-47. PubMed ID: 28395802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient carrying the N551K variant in LRRK2 gene.
    Ma D; Ng EY; Zeng L; Lim CY; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():51-53. PubMed ID: 28395804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation and characterization of a human induced pluripotent stem cell (iPSC) line (HEBHMUi001-A) from a sporadic Parkinson's disease patient.
    Ma J; Guo R; Song Y; Zhang J; Feng B; Amponsah AE; Kong D; He J; Zhang W; Liu A; Wei L; Shen S; O'Brien T; Cui H
    Stem Cell Res; 2019 Apr; 36():101417. PubMed ID: 30875588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of two iPSC lines, (ICGi015-A and ICGi015-B), by reprogramming peripheral blood mononuclear cells from a patient with Parkinson's disease.
    Sharipova DV; Kovalenko VR; Bairamova EM; Vartanova VA; Grigor'eva EV; Vyatkin YV; Khabarova EA; Rzaev DA; Zakian SM; Medvedev SP
    Stem Cell Res; 2019 Dec; 41():101652. PubMed ID: 31733442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.